Dyadic International, Inc. (NASDAQ:DYAI) Q1 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, good evening, and welcome to Dyadic International's Q1 2024 Conference Call. Currently, all participants are in a listen-only mode.
Stay updated with breaking news from Cell Protein. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Ladies and gentlemen, good evening, and welcome to Dyadic International's Q1 2024 Conference Call. Currently, all participants are in a listen-only mode.
Dyadic International, Inc. misses on earnings expectations. Reported EPS is $-0.08 EPS, expectations were $-0.07.
Dr. Michael Lim Ming Soon's Cell Genesis Laboratories Announces a Pioneering ...
PETALING JAYA, MALAYSIA / ACCESSWIRE / September 9, 2023 / Under the esteemed guidance of Dr. Michael Lim Ming Soon, Cell Genesis Laboratories has unveiled a pioneering approach in regenerative medicine, harnessing the
For this to occur, what we think has to happen is first of all the virus vaccine has to be leaked to a small extent into the bloodstream, where it may or may not then interact with this key protein called pf4. that is the crux of the paper. we discuss and show how that interaction can occur. following on from that, there is a significant number of other steps which have to occur before blood clotting happens. that complex has to be trafficked to the lymph, and you have to then have a misplaced immune response within your immune system that results in the production of anti—pfli antibodies. w...